PortfoliosLab logoPortfoliosLab logo
CRNX vs. CCL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRNX vs. CCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Crinetics Pharmaceuticals, Inc. (CRNX) and Carnival Corporation & Plc (CCL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRNX achieves a 80.26% return, which is significantly higher than CCL's -11.10% return.


CRNX

1D
0.01%
1M
139.74%
6M
48.70%
YTD
80.26%
1Y
163.04%
3Y*
61.39%
5Y*
33.59%
10Y*

CCL

1D
1.02%
1M
-13.07%
6M
-7.78%
YTD
-11.10%
1Y
-6.51%
3Y*
15.30%
5Y*
5.35%
10Y*
-3.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CRNX vs. CCL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CRNX
Crinetics Pharmaceuticals, Inc.
80.26%-8.96%43.70%94.43%-35.59%101.35%-43.76%-16.34%55.79%
CCL
Carnival Corporation & Plc
-11.10%22.55%34.41%130.02%-59.94%-7.11%-56.89%7.37%-14.46%

Correlation

The correlation between CRNX and CCL is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Jul 18, 2018

0.24

Fundamentals

Market Cap

CRNX:

$8.88B

CCL:

$36.79B

EPS

CRNX:

-$5.09

CCL:

$2.20

PS Ratio

CRNX:

517.80

CCL:

1.37

PB Ratio

CRNX:

6.82

CCL:

2.87

Total Revenue (TTM)

CRNX:

$15.79M

CCL:

$27.31B

Gross Profit (TTM)

CRNX:

$16.05M

CCL:

$9.40B

EBITDA (TTM)

CRNX:

-$531.75M

CCL:

$7.16B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRNX vs. CCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRNX
CRNX Risk / Return Rank: 9191
Overall Rank
CRNX Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
CRNX Sortino Ratio Rank: 9797
Sortino Ratio Rank
CRNX Omega Ratio Rank: 9696
Omega Ratio Rank
CRNX Calmar Ratio Rank: 9191
Calmar Ratio Rank
CRNX Martin Ratio Rank: 8686
Martin Ratio Rank

CCL
CCL Risk / Return Rank: 3737
Overall Rank
CCL Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
CCL Sortino Ratio Rank: 3737
Sortino Ratio Rank
CCL Omega Ratio Rank: 3737
Omega Ratio Rank
CCL Calmar Ratio Rank: 3737
Calmar Ratio Rank
CCL Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRNX vs. CCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Crinetics Pharmaceuticals, Inc. (CRNX) and Carnival Corporation & Plc (CCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CRNXCCLDifference
Sharpe ratioReturn per unit of total volatility

+1.58

Sortino ratioReturn per unit of downside risk

+4.08

Omega ratioGain probability vs. loss probability

1.51

1.02

+0.49

Calmar ratioReturn relative to maximum drawdown

3.89

-0.22

+4.11

Martin ratioReturn relative to average drawdown

7.58

-0.43

+8.01

CRNX vs. CCL - Sharpe Ratio Comparison

The current CRNX Sharpe Ratio is 1.44, which is higher than the CCL Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of CRNX and CCL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CRNX vs. CCL - Drawdown Comparison

The maximum CRNX drawdown since its inception was -68.70%, smaller than the maximum CCL drawdown of -90.37%. Use the drawdown chart below to compare losses from any high point for CRNX and CCL.


Loading charts...

Drawdown Indicators


CRNXCCLDifference

Max Drawdown

Largest peak-to-trough decline

-68.70%

-90.37%

+21.67%

Max Drawdown (1Y)

Largest decline over 1 year

-42.21%

-29.30%

-12.91%

Max Drawdown (3Y)

Largest decline over 3 years

-57.88%

-42.33%

-15.55%

Max Drawdown (5Y)

Largest decline over 5 years

-57.88%

-75.82%

+17.94%

Max Drawdown (10Y)

Largest decline over 10 years

-90.37%

Current Drawdown

Current decline from peak

0.00%

-59.00%

+59.00%

Average Drawdown

Average peak-to-trough decline

-37.19%

-28.64%

-8.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.59%

15.33%

+6.26%

Volatility

CRNX vs. CCL - Volatility Comparison

Crinetics Pharmaceuticals, Inc. (CRNX) has a higher volatility of 68.66% compared to Carnival Corporation & Plc (CCL) at 10.94%. This indicates that CRNX's price experiences larger fluctuations and is considered to be riskier than CCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRNXCCLDifference

Volatility (1M)

Calculated over the trailing 1-month period

68.66%

10.94%

+57.72%

Volatility (6M)

Calculated over the trailing 6-month period

76.87%

38.47%

+38.40%

Volatility (1Y)

Calculated over the trailing 1-year period

113.77%

47.14%

+66.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.71%

55.50%

+22.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.27%

57.67%

+16.60%

Dividends

CRNX vs. CCL - Dividend Comparison

CRNX has not paid dividends to shareholders, while CCL's dividend yield for the trailing twelve months is around 1.12%.


PositionTTM20252024202320222021202020192018201720162015
CCL
Carnival Corporation & Plc
1.12%0.00%0.00%0.00%0.00%0.00%2.31%3.93%3.96%2.41%2.59%2.02%
CRNX
Crinetics Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

CRNX vs. CCL - Financials Comparison

This section allows you to compare key financial metrics between Crinetics Pharmaceuticals, Inc. and Carnival Corporation & Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
10.73M
6.66B
(CRNX) Total Revenue
(CCL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CRNX and CCL have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRNX has higher volatility (68.66%) compared to CCL (10.94%). In terms of maximum drawdown, CRNX dropped -68.70% vs CCL's -90.37%.

CRNX currently has the higher Sharpe Ratio (1.44 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRNX and CCL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer